Quantification of MRI lesion load in multiple sclerosis: A comparison of three computer-assisted techniques

Magnetic Resonance Imaging

Volumn 14, Issue 5, 1996, Pages 495-505

  Grimaud, J ^a   Lai, M ^a   Thorpe, J ^a   Adeleine, P ^a   Wang, L ^a   Barker, G J ^a   Plummer, D L ^a   Tofts, P S ^a   McDonald, W I ^a   Miller, David H ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Brain magnetic resonance imaging; Lesion volume measurement; Multiple sclerosis; Precision; Repeatability; Reproducibility

Indexed keywords

ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED DIAGNOSIS; DISEASE ACTIVITY; HUMAN; MONITORING; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0029814538     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0730-725X(96)00018-5     Document Type: Article

References (29)

1. 1. Miller, D.H.; Barkhof, F.; Berry, I.; Kappos, L.; Scotti, G.; Thompson, A.J. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: Concerted action guidelines. J. Neurol. Neurosurg. Psychiatry 54:689-694; 1991.
2. 2. Paty, D.W.; Li, D.K.B.; Oger J.J-F.; et al. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis. Ann. Neurol. 36:S95-S96; 1994.
3. 3. Poser, C.M.; Paty, D.W.; Scheinberg, L.; et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann. Neurol. 13:227-231; 1983.
4. 4. Kurtzke, J.F. Rating neurologic impairment in multiple sclerosis: An expanded disability scale (EDSS). Neurology 33:1444-1452; 1983.
5. 5. Wicks, D.A.G.; Tofts, P.S.; Miller, D.H.; et al. Volume measurement of multiple sclerosis lesions with magnetic resonance images. Neuroradiology 34:475-479; 1992.
6. 6. Plummer, D.L. DispImage: Un mezzo di analisi e presentazione per iconografia medica (DispImage: a display and analysis tool for medical images). Riv. Neuroradiol. 5:489-495; 1992.
7. 7. Tukey, J.W. Tukey exploratory data analysis. Reading, MA: Addison Weseley; 1977.
8. 8. Altman, D.G.; Bland, J.M. Measurement in medicine: The analysis of method comparison studies. Statistician 32:307-317; 1983.
9. 9. Bland, J.M.; Altman, D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 8:307-310; 1986.
10. 10. British Standards. Precision of test methods. Part I. Guide for the determination of "reproducibility" and reproducibility for a standard test method by inter-laboratory tests. British Standard Institution BS 5497; 1987.
11. 11. Normes AFNOR. Statistiques. Tome 3. Traitement des résultats de mesures; 1993.
12. 12. Zar, J. Measures of dispersion and variability. Biostatistical Analysis. 2nd ed. Englewood Cliffs, NJ: Prentice Hall International Inc.; 1984:27-39.
13. 13. Goodkin, D.E.; Ross, J.S.; Medendorp, S.M.; Konecsni, J.; Rudick, A. Magnetic resonance imaging lesion enlargement in multiple sclerosis. Disease-related activity, chance occurance, or measurement artifact? Arch. Neurol. 49:261-263; 1992.
14. 14. Kastrukoff, L.F.; Oger, J.J.; Hashimoto, S.A.; et al. Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation. Neurology 40:479-486; 1990.
15. 15. Koopmans, R.A.; Li, D.K.B.; Zhao, G.J.; Redekop, W.K.; Paty, D.W. MRI assessment of cyclosporine therapy of MS in a multi-center trial abstract. Neurology 42(Suppl 3):210; 1992.
16. 16. The INFβ Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I: Clinical results of a multicenter, randomised, double-blind, placebo-controlled trial. Neurology 43:655-661; 1993.
17. 17. Koopmans, R.A.; Li, D.K.B.; Redekop, W.K.; et al. The use of magnetic resonance imaging in monitoring interferon therapy of multiple sclerosis. J. Neuroimaging 3:163-168; 1993.
18. 18. Paty, D.W.; Li, D.K.B.; the UBC MS/MRI Study group, and the INFB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, plcebo controlled trial. Neurology 43:662-667; 1993.
19. 19. Paty, D.W.; Issac, C.D.; Grochowski, E.; et al. Magnetic resonance imaging (MRI) in multiple sclerosis (MS): A serial study in relapsing and remitting patients with quantitative measurements of lesion size abstract. Neurology 36(Suppl. 1): 177; 1986.
20. 20. Filippi, M.; Horsfield, M.A.; Bressi, S.; et al. Intra-and inter-observer agreement of brain MRI lesion volume measurements in multiple sclerosis: A comparison of techniques. Brain 1995; 118:1593-1600.
21. 21. Filippi, M.; Barker, G.J.; Horsfield, M.A.; et al. Benign secondary progressive multiple sclerosis: A preliminary quantitative MRI study. J. Neurol. 241:246-251; 1994.
22. 22. Gass, A.; Barker, G.J.; Kidd, D.; et al. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann. Neurol. 36:62-67; 1994.
23. 23. Hajnal, J.V.; Bryant, D.J.; Kasuboski, L.; et al. Use of fluid attenuated inversion recovery (FLAIR) pulse sequence in MRI of the brain. J. Comput. Assist. Tomogr. 16:841-844; 1992.
24. 24. De Coene, B.; Hajnal, J.V.; Gatehouse, P.; et al. MR of the brain using fluid-attenuated inversion recovery (FLAIR) pulse sequences. Am. J. Neuroradiol. 13:1555-1564; 1992.
25. 25. Thomas, D.J.; Pennock, J.M.; Hajnal, J.V.; Young, I.R.; Bydder, G.M.; Steiner, R.E. Magnetic resonance imaging of spinal cord in multiple sclerosis by fluid-attenuated inversion recovery. Lancet 341:593-594; 1993.
26. 26. Rydberg, J.N.; Hammond, C.A.; Grimm, R.C.; et al. Initial clinical experience in MR imaging of the brain with a fast fluid-attenuated inversion-recovery pulse sequence. Radiology 193:173-180; 1994.
27. 27. Cline, H.E.; Lorensen, W.E.; Kikinis, R.; Jolesz, F. Three-dimensional segmentation of MR images of the head using probability and connectivity. J. Comput. Assist. Tomogr. 14:1037-1045; 1990.
28. 28. Ross Mitchell, J.; Karlik, S.J.; Lee, D.H.; Fenster, A. Computer-assisted identification and quantification of multiple sclerosis lesions in MR imaging volumes in the brain. J. Magn. Reson. Imaging 4:197-208; 1994.
29. 29. Clarke, L.P.; Velthuizen, R.P.; Camacho, M.A.; et al. MRI segmentation: Methods and applications. Magn. Reson. Imaging 13:343-368; 1995.